The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225
Open accessAbstract
Purpose: To investigate the feasibility of intensity-modulated radiation therapy (IMRT) with or without chemotherapy, and to assess toxicities, failure patterns, and survivals in patients with nasopharyngeal carcinoma (NPC). Patients and Methods: Radiation consisted of 70 Gy given to the planning target volumes of primary tumor plus any N+ disease and 59.4 Gy given to subclinical disease, delivered over 33 treatment days. Patients with stage T2b or greater or with N+ disease also received concurrent cisplatin (100 mg/m 2) on days 1, 22, and 43 followed by adjuvant cisplatin (80 mg/m 2) on day 1; fluorouracil (1,000 mg/m 2/d) on days 1 through 4 administered every 4 weeks for three cycles. Tumor, clinical status, and acute/late toxicities were assessed. The primary objective was to test the transportability of IMRT to a multi-institutional setting. Results: Between February 2003 and November 2005, 68 patients with stages I through IVB NPC (of which 93.8% were WHO types 2 and 3) were enrolled. Prescribed IMRT (target delineation) was given to 83.8%, whereas 64.9% received chemotherapy per protocol. The estimated 2-year local progression-free (PF), regional PF, locoregional PF, and distant metastasis–free rates were 92.6%, 90.8%, 89.3%, and 84.7%, respectively. The estimated 2-year PF and overall survivals were 72.7% and 80.2%, respectively. Acute grade 4 mucositis occurred in 4.4%, and the worst late grade 3 toxicities were as follows: esophagus, 4.7%; mucous membranes, 3.1%; and xerostomia, 3.1%. The rate of grade 2 xerostomia at 1 year from start of IMRT was 13.5%. Only two patients complained of grade 3 xerostomia, and none had grade 4 xerostomia. Conclusion: It was feasible to transport IMRT with or without chemotherapy in the treatment of NPC to a multi-institutional setting with 90% LRPF rate reproducing excellent reports from single institutions. Minimal grade 3 and lack of grade 4 xerostomia were encouraging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Al-Sarraf, M., LeBlanc, M., Giri, P. G., Fu, K. K., Cooper, J., Vuong, T., Forastiere, A. A., Adams, G., Sakr, W. A., Schuller, D. E., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1310 · Cited by 2,222
One-Sample Multiple Testing Procedure for Phase II Clinical Trials
Fleming, T. R. (1982) · Biometrics · doi:10.2307/2530297 · Cited by 1,003
Lee, N., Xia, P., Quivey, J. M., Sultanem, K., Poon, I., Akazawa, C., Akazawa, P., Weinberg, V., & Fu, K. K. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02724-4 · Cited by 986
Self-citationLin, J.-C., Jan, J.-S., Hsu, C.-Y., Liang, W.-M., Jiang, R.-S., & Wang, W.-Y. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.158 · Cited by 762
Pow, E. H. N., Kwong, D. L. W., McMillan, A. S., Wong, M. C. M., Sham, J. S. T., Leung, L. H. T., & Leung, W. K. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.06.013 · Cited by 737
Lee, A. W. M., Poon, Y. F., Foo, W., Law, S. C. K., Cheung, F. K., Chan, D. K. K., Tung, S. Y., Thaw, M., & Ho, J. H. C. (1992) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)90740-9 · Cited by 654
Wee, J., Tan, E. H., Tai, B. C., Wong, H. B., Leong, S. S., Tan, T., Chua, E. T., Yang, E., Lee, K. M., Fong, K. W., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.16.790 · Cited by 650
Treatment results for nasopharyngeal carcinoma in the modern era: The Hong Kong experience
Lee, A. W. M., Sze, W. M., Au, J. S. K., Leung, S. F., Leung, T. W., Chua, D. T. T., Zee, B. C. Y., Law, S. C. K., Teo, P. M. L., Tung, S. Y., et al. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.07.702 · Cited by 587
Late effects of radiation therapy in the head and neck region
Cooper, J. S., Fu, K., Marks, J., & Silverman, S. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)00421-g · Cited by 453
Lee, A. W. M., Lau, W. H., Tung, S. Y., Chua, D. T. T., Chappell, R., Xu, L., Siu, L., Sze, W. M., Leung, T. W., Sham, J. S. T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.7542 · Cited by 449
Langendijk, J. A., Leemans, C. R., Buter, J., Berkhof, J., & Slotman, B. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.074 · Cited by 409
Carcinoma of the nasopharynx.Eighteen years' experience with megavoltage radiation therapy
Hoppe, R. T., Goffinet, D. R., & Bagshaw, M. A. (1976) · Cancer · Cited by 224
Eisbruch, A., Ship, J. A., Martel, M. K., Ten Haken, R. K., Marsh, L. H., Wolf, G. T., Esclamado, R. M., Bradford, C. R., Terrell, J. E., Gebarski, S. S., et al. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00264-7 · Cited by 218
Patterns of failure in carcinoma of the nasopharynx: I. failure at the primary site
Vikram, B., Mishra, U. B., Strong, E. W., & Manolatos, S. (1985) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(85)90332-3 · Cited by 181
Some factors influencing salivary function when treating with radiotherapy
Mira, J. G., Wescott, W. B., Starcke, E. N., & Shannon, I. L. (1981) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(81)90140-1 · Cited by 162
Leslie, M. D., & Dische, S. (1994) · Radiotherapy and Oncology · doi:10.1016/0167-8140(94)90006-x · Cited by 113
Wakisaka, N., Wen, Q.-H., Yoshizaki, T., Nishimura, T., Furukawa, M., Kawahara, E., & Nakanishi, I. (1999) · The Laryngoscope · doi:10.1097/00005537-199905000-00024 · Cited by 82
Effect of Radiotherapy on Whole Saliva Flow
Shannon, I. L., Starcke, E. N., & Wescott, W. B. (1977) · Journal of Dental Research · doi:10.1177/00220345770560062201 · Cited by 81
Osteoradionecrosis of the mandible: a review.
Jm, B., & Sutherland, S. E. (1989) · PubMed · Cited by 81
Cited by
Chua, M. L. K., Wee, J. T. S., Hui, E. P., & Chan, A. T. C. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00055-0 · Cited by 1,236
Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective
Lee, A. W. M., Ma, B. B. Y., Ng, W. T., & Chan, A. T. C. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.60.9347 · Cited by 796
Tang, L., Chen, Y., Chen, C., Chen, M., Chen, N., Chen, X., Du, X., Fang, W., Feng, M., Gao, J., et al. (2021) · Cancer Communications · doi:10.1002/cac2.12218 · Cited by 413
Chen, Y.-P., Ismaila, N., Chua, M. L. K., Colevas, A. D., Haddad, R., Huang, S. H., Wee, J. T. S., Whitley, A. C., Yi, J.-L., Yom, S. S., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.03237 · Cited by 390
Self-citationLee, A. W., Ng, W. T., Pan, J. J., Poh, S. S., Ahn, Y. C., AlHussain, H., Corry, J., Grau, C., Grégoire, V., Harrington, K. J., et al. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.10.032 · Cited by 367
Self-citation
Metadata
- Authors
- Lee, N., Harris, J., Garden, A. S., Straube, W., Glisson, B., Xia, P., Bosch, W., Morrison, W. H., Quivey, J., Thorstad, W., Jones, C., & Ang, K. K.
- Venue
- Journal of Clinical Oncology
- Published
- 2009-08-01
- Volume
- 27
- Issue
- 22
- Pages
- 3684-3690
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2113470349
- Cited by
- 706
- References
- 21
- FWCI
- 29.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.